We are live on ! Find out more
GAA

Green Alpha Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 118.1%
This Fund
S&P 500
This Quarter Est. Return
+65.5%
1 Year Est. Return
+118.1%
3 Year Est. Return
+267.27%
5 Year Est. Return
+298.06%
10 Year Est. Return
AUM
$149M
AUM Growth
+$47.5M
Cap. Flow
+$1.31M
Cap. Flow %
0.88%
Top 10 Hldgs %
42.29%
Holding
113
New
6
Increased
40
Reduced
67
Closed

Top Buys

Rank Stock Value
1
NXTE icon
AXS Green Alpha ETF
NXTE
+$2.44M
2
BEAM icon
Beam Therapeutics
BEAM
+$229K
3
YETI icon
Yeti Holdings
YETI
+$227K
4
TXG icon
10x Genomics
TXG
+$219K
5
AZTA icon
Azenta
AZTA
+$199K

Sector Composition

Rank Sector Weight
1 Technology 62.33%
2 Healthcare 12.52%
3 Industrials 7.73%
4 Consumer Discretionary 4.56%
5 Utilities 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
101
Regeneron Pharmaceuticals
REGN
$81.8B
$213K 0.14%
341
+5
+1% +$3.4K
GTLB icon
102
GitLab
GTLB
$7.58B
$212K 0.14%
+6,937
New +$176K
ARCT icon
103
Arcturus Therapeutics
ARCT
$432M
$182K 0.12%
27,091
-1,047
-4% -$8.25K
ABCL icon
104
AbCellera Biologics
ABCL
$3.68B
$172K 0.12%
21,916
-1,028
-4% -$5.03K
SHLS icon
105
Shoals Technologies Group
SHLS
$1.2B
$161K 0.11%
16,247
+217
+1% +$1.97K
DNA icon
106
Ginkgo Bioworks
DNA
$469M
$134K 0.09%
13,546
-230
-2% -$1.92K
MBLY icon
107
Mobileye
MBLY
$7.29B
$132K 0.09%
13,587
+121
+0.9% +$1.08K
GWH icon
108
ESS Tech
GWH
$13.8M
$110K 0.07%
115,775
+1,195
+1% +$1.19K
RPD icon
109
Rapid7
RPD
$896M
$82.9K 0.06%
+10,230
New +$67.8K
INO icon
110
Inovio Pharmaceuticals
INO
$133M
$74.9K 0.05%
68,055
+2,475
+4% +$2.94K
ECX icon
111
ECARX Holdings
ECX
$413M
$67.3K 0.05%
52,202
+2,842
+6% +$3.24K
BEEM icon
112
Beam Global
BEEM
$32.6M
$52.7K 0.04%
40,505
+1,080
+3% +$1.66K
QSI icon
113
Quantum-Si Incorporated
QSI
$171M
$40.6K 0.03%
45,921
+2,713
+6% +$2.58K

Similar funds

Green Alpha Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Green Alpha Advisors held 113 positions worth $149M, up 47% from $102M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Green Alpha Advisors's Q2 2026 filing shows 6 new, 40 increased and 67 reduced positions. Its largest new stake was Beam Therapeutics: 7,569 shares worth $260K. The largest sale was Horizon Technology Finance, an estimated $693K.

By sector, the portfolio is most concentrated in Technology at 62% of assets, up from 56% a quarter earlier, followed by Healthcare and Industrials.

  • Green Alpha Advisors's largest Q2 2026 buy was Beam Therapeutics: 7,569 shares worth $260K.
  • Green Alpha Advisors added most to AXS Green Alpha ETF in Q2 2026, an estimated $2.44M increase.
  • Green Alpha Advisors's biggest Q2 2026 reduction was Horizon Technology Finance, cutting an estimated $693K.
  • Green Alpha Advisors's ten largest holdings make up 42% of its $149M portfolio in Q2 2026.
  • Green Alpha Advisors opened 6 new positions and closed 0 in Q2 2026.
  • Green Alpha Advisors's portfolio value rose 47% quarter-over-quarter to $149M.

Based on Green Alpha Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.